We evaluated  the association of a polymorphism in TCF7L2 RS12255372 in the WNT signaling pathway, which previously has been strongly associated with risk of Type II Diabetes, with colorectal cancer (CRC) and adenoma in the prospective Nurses' Health Study (NHS) and Health ProfessionalsFollow-up Study (HPFS) cohorts.